Ra Capital Management, L.P.

Source: SEC Form 13F · as of Mar 2026

Ra Capital Management, L.P. holds 74 biotech & pharma companies tracked by BioSniper, totaling $6.93B in value as of Mar 2026 (SEC Form 13F).

Companies held

74

Total value held

$6.93B

CompanySharesValue
PCVXVaxcyte, Inc.11,474,599$666.8M
RYTMRHYTHM PHARMACEUTICALS, INC.6,666,837$579.8M
TYRATyra Biosciences, Inc.12,198,625$467.2M
SIONSionna Therapeutics, Inc.9,905,045$397.1M
EWTXEdgewise Therapeutics, Inc.10,428,437$328.5M
NAMSNEWAMSTERDAM PHARMA CO N.V.9,550,191$305.7M
NUVLNuvalent, Inc.2,534,145$259.6M
DNTHDianthus Therapeutics, Inc. /DE/2,611,733$219.2M
MLYSMineralys Therapeutics, Inc.7,692,750$208.4M
SGPSpyGlass Pharma Inc.8,021,117$207.8M
WVEWave Life Sciences Ltd.26,975,505$195.6M
SEPNSepterna, Inc.6,995,858$168.1M
IRONDisc Medicine, Inc.2,450,221$156.7M
JANXJanux Therapeutics, Inc.11,189,693$155.5M
BCRXBIOCRYST PHARMACEUTICALS INC15,827,186$150.7M
BCAXBicara Therapeutics Inc.7,255,993$144.3M
PRAXPraxis Precision Medicines, Inc.373,787$120.4M
GHRSGH Research PLC7,676,697$107.9M
ZLABZai Lab Ltd5,707,262$107.4M
TSHATaysha Gene Therapies, Inc.23,555,648$105.3M
VORVor Biopharma Inc.5,404,998$96.4M
GERNGERON CORP63,771,366$95.0M
SPRYARS Pharmaceuticals, Inc.10,860,977$87.2M
SRPTSarepta Therapeutics, Inc.3,902,596$84.9M
SYRESpyre Therapeutics, Inc.1,621,620$81.8M
EVMNEvommune, Inc.3,494,638$80.3M
CLYMClimb Bio, Inc.11,300,939$77.4M
SLDBSolid Biosciences Inc.9,339,978$67.2M
ARTVArtiva Biotherapeutics, Inc.9,853,302$63.5M
DMRADamora Therapeutics, Inc.2,399,310$62.1M
XNCRXencor Inc4,897,237$59.1M
LBRXLB PHARMACEUTICALS INC2,208,604$54.5M
JBIOJade Biosciences, Inc.3,671,083$51.6M
ABOSAcumen Pharmaceuticals, Inc.20,992,669$49.5M
FDMT4D Molecular Therapeutics, Inc.5,049,779$47.0M
FULCFulcrum Therapeutics, Inc.6,053,960$46.4M
CAPRCAPRICOR THERAPEUTICS, INC.1,507,844$45.8M
IPSCCentury Therapeutics, Inc.17,754,430$40.1M
OLMAOlema Pharmaceuticals, Inc.2,600,000$38.8M
LENZLENZ Therapeutics, Inc.4,178,823$38.2M
MNPRMonopar Therapeutics667,207$36.6M
PEPGPepGen Inc.20,064,545$35.5M
DSGNDesign Therapeutics, Inc.2,972,973$31.6M
MIRMMirum Pharmaceuticals, Inc.318,554$29.4M
BIOABioAge Labs, Inc.1,650,648$28.9M
ASMBASSEMBLY BIOSCIENCES, INC.1,020,410$28.3M
RZLTRezolute, Inc.9,180,000$28.0M
AKTSAktis Oncology Inc.1,503,084$26.9M
ALXOALX ONCOLOGY HOLDINGS INC13,011,849$26.1M
ACRSAclaris Therapeutics, Inc.6,804,072$25.5M
OVIDOvid Therapeutics Inc.10,714,000$23.8M
NKTXNkarta, Inc.10,805,129$22.8M
TVTXTravere Therapeutics, Inc.746,841$22.2M
CCCCC4 Therapeutics, Inc.8,000,000$21.0M
RLMDRELMADA THERAPEUTICS, INC.2,947,369$20.5M
BNTCBenitec Biopharma Inc.1,850,000$19.7M
DRUGBRIGHT MINDS BIOSCIENCES INC.265,000$19.3M
STROSUTRO BIOPHARMA, INC.715,307$17.8M
SABSSAB BIOTHERAPEUTICS, INC.4,401,500$16.9M
INSPInspire Medical Systems Inc.325,663$16.8M
OKUROnKure Therapeutics, Inc.3,998,333$16.6M
PALIPALISADE BIO, INC.7,124,116$12.5M
ACRVAcrivon Therapeutics, Inc.8,340,508$11.6M
RNAAtrium Therapeutics Inc.864,102$11.6M
KPTIKaryopharm Therapeutics Inc.1,917,354$10.7M
AVTXAvalo Therapeutics, Inc.662,968$9.9M
ACETAdicet Bio, Inc.1,182,624$8.1M
CRVSCorvus Pharmaceuticals, Inc.450,000$6.6M
RANIRani Therapeutics Holdings, Inc.8,500,000$6.2M
EQEquillium, Inc.3,096,336$6.2M
HOWLWerewolf Therapeutics, Inc.6,681,307$5.6M
MGNXMACROGENICS INC1,864,176$5.4M
MPLTMapLight Therapeutics, Inc.248,294$5.0M
PTNPALATIN TECHNOLOGIES INC70,000$1.2M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.